Incyte Corporation (INCY)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $24.51B
Last updated: Nov 17, 2026 at 4:35 PM ET
Incyte Corporation (INCY) Statistics
Incyte (INCY) has a market cap of $24.51B and an enterprise value of $21.31B. Revenue grew 24.88% over the last 12 months from the 12 months before. Its trailing P/E of 45.5x is above its 5-year median of 24.9x.
Total Valuation
Enterprise value is 13.09% below the market cap, as cash exceeds debt.
| Market Cap | $24.51B |
|---|---|
| Enterprise Value | $21.31B |
| Latest price (Nov 17, 2026) | $119.09 |
Key Dates
The next earnings report is expected on Feb 8, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 8, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 29, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 4.0x and 4.3x. Its year-end P/E ranged from 14.5x to 185.7x from 2016 to 2025.
| P/E Ratio | 45.5x |
|---|---|
| Forward P/E | 34.5x |
| P/S Ratio | 4.0x |
| Forward P/S | 4.0x |
| P/B Ratio | 4.3x |
| P/TBV Ratio | 4.5x |
| P/FCF Ratio | 35.3x |
| P/OCF Ratio | 32.9x |
Enterprise Valuation
Counting debt and cash, the company is valued at 28.3x EBITDA and 30.7x free cash flow.
| EV / Earnings | 52.8x |
|---|---|
| EV / Sales | 3.5x |
| EV / EBITDA | 28.3x |
| EV / FCF | 30.7x |
Price Statistics
The stock is up 14.34% over 52 weeks and trades 0.13% above its 50-day average.
| Beta (1Y) | 0.45 |
|---|---|
| 52-Week Change | +14.34% |
| 1-Month Change | +5.16% |
| 3-Month Change | -7.30% |
| 6-Month Change | +24.57% |
| 5-Year Change | +79.74% |
| 10-Year Change | +38.43% |
| Total Return (1Y) | +14.34% |
| Total Return (3Y CAGR) | +29.94% |
| Total Return (5Y CAGR) | +12.84% |
| Return vs SPY (1Y) | +3.07% |
| Max Drawdown (1Y) | -18.33% |
| Max Drawdown (3Y) | -33.83% |
| Sharpe Ratio (1Y) | 0.42 |
| Correlation with SPY (1Y) | 0.19 |
| 50-Day Average | $118.94 |
| 200-Day Average | $109.10 |
| 52-Week Range | $89.25 to $132.60 |
| RSI (14 Days) | 50.3 |
| Average Volume (20 Days) | 1.82M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 3.84x current liabilities, and total debt is 0.01x shareholder equity.
| Current Ratio | 3.84x |
|---|---|
| Quick Ratio | 3.75x |
| Debt / Equity | 0.01x |
| Debt / EBITDA | 0.09x |
| Debt / FCF | 0.10x |
| Interest Coverage | 274.76x |
Returns and Efficiency
Return on invested capital is 7.31% over the last 12 months, against a 5-year average of 22.85%.
| Return on Equity (ROE) | 7.15% |
|---|---|
| Return on Assets (ROA) | 5.54% |
| Return on Invested Capital (ROIC) | 7.31% |
| ROE (5Y Average) | 14.06% |
| ROA (5Y Average) | 10.59% |
| ROIC (5Y Average) | 22.85% |
| Asset Turnover | 0.88x |
| Inventory Turnover | 3.56x |
| Receivables Turnover | 5.09x |
| Cash Conversion Cycle | -28 days |
Taxes
Income tax took 49.33% of pretax income over the last 12 months.
| Income Tax (TTM) | $392.80M |
|---|---|
| Effective Tax Rate | 49.33% |
Scores
INCY has an Altman Z-Score of 10.68, in the safe zone above 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 10.68 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 7 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue was $6.01B over the last 12 months.
| Revenue | $6.01B |
|---|---|
| Revenue Growth (YoY) | +24.88% |
| Gross Profit | $5.57B |
| Operating Income | $626.51M |
| Pretax Income | $796.21M |
| Net Income | $403.41M |
| Reported EPS (TTM) | $2.62 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 77.37% of the $7.29B in total assets.
| Cash and Equivalents | $3.28B |
|---|---|
| Total Debt | $67.54M |
| Net Cash | $3.21B |
| Net Cash Per Share | $15.79 |
| Working Capital | $4.08B |
| Shareholder Equity | $5.64B |
| Book Value Per Share | $27.76 |
| Tangible Book Value | $5.41B |
| Tangible Book Per Share | $26.60 |
| Total Assets | $7.29B |
| Total Liabilities | $1.64B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $60.12M of capital spending, operating cash flow left $684.87M of free cash flow.
| Operating Cash Flow | $744.99M |
|---|---|
| Capital Expenditures | $60.12M |
| Free Cash Flow | $684.87M |
| FCF Per Share | $3.38 |
| Depreciation and Amortization | $98.44M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 10.42%, against a 5-year average of 16.88%.
| Gross Margin | 92.69% |
|---|---|
| Operating Margin | 10.42% |
| Pretax Margin | 13.25% |
| Net Margin | 6.71% |
| FCF Margin | 11.39% |
| Gross Margin (5Y Average) | 93.47% |
| Operating Margin (5Y Average) | 16.88% |
| Net Margin (5Y Average) | 16.75% |
Growth
Revenue grew 14.84% a year over 3 years, and EPS 34.67% a year.
| Revenue Growth (3Y CAGR) | +14.84% |
|---|---|
| Revenue Growth (5Y CAGR) | +14.03% |
| EPS Growth (3Y CAGR) | +34.67% |
| FCF Growth (3Y CAGR) | +14.94% |
| Operating Income Growth (3Y CAGR) | +37.76% |
| Book Value Per Share Growth (2Y CAGR) | +4.86% |
| Tangible Book Per Share Growth (2Y CAGR) | +5.16% |
Dividends and Yields
INCY does not pay a dividend. Its free cash flow yield is 2.83%.
| Earnings Yield | 2.20% |
|---|---|
| FCF Yield | 2.83% |
| Buyback Yield | -1.88% |
| Shareholder Yield | -1.88% |
Stock Splits
The last split was a 2-for-1 forward split on Sep 1, 2000.
| Last Split Date | Sep 1, 2000 |
|---|---|
| Split Type | Forward split |
| Split Ratio | 2:1 |
Analyst Forecast
Consensus estimates put revenue growth at 10.77% and EPS growth at 12.80% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +10.77% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +12.80% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Overvalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About INCY
What is INCY's market cap?
Incyte has a market cap of $24.51B. Its enterprise value, which adds debt and subtracts cash, is $21.31B.
What is INCY's P/E ratio?
Incyte has a trailing P/E ratio of 45.5x and a forward P/E of 34.5x.
How many shares of INCY are outstanding?
Incyte has 203.25M shares outstanding. The count is up 3.87% from a year earlier.
Does INCY pay a dividend?
No. Incyte does not pay a dividend.
How much debt does INCY have?
Incyte has $67.54M of total debt and $3.28B of cash and equivalents, a net cash position of $3.21B.
INCY pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation